Identifying functional cuproptosis-related long non-coding RNAs in patients with bladder cancer
- Yunchao Wang 1, Yihan Zhao 1, Qing Liu 2, Jiwei Yang 1, Zhipeng Xu 1, Wenzhi Du 1, Guanbao Tang 1, Chuanpai Zhang 1, Xiaoqing Si 3, Jianning Wang 1
- Yunchao Wang 1, Yihan Zhao 1, Qing Liu 2
- 1Department of Urology, the First Affiliated Hospital of Shandong First Medical University, Jinan, China.
- 2Department of Medical Ultrasound, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
- 3Department of Dermatology, the First Affiliated Hospital of Shandong First Medical University, Jinan, China.
- 0Department of Urology, the First Affiliated Hospital of Shandong First Medical University, Jinan, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study reveals cuproptosis-related long non-coding RNAs (lncRNAs) are key in bladder cancer development. A new prognostic signature using these lncRNAs can predict patient survival and guide treatment strategies.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- Bladder cancer is a prevalent urinary tract malignancy worldwide.
- Cuproptosis, a novel cell death pathway, is implicated in cancer development.
- Understanding cuproptosis-related genes is crucial for bladder cancer research.
Purpose Of The Study
- To investigate the correlation between cuproptosis-related genes and bladder cancer tumorigenesis.
- To develop a prognostic signature for bladder cancer based on cuproptosis-related long non-coding RNAs (lncRNAs).
- To evaluate the predictive power of the developed signature for patient survival.
Main Methods
- Utilized Pearson correlation and univariate Cox regression on The Cancer Genome Atlas (TCGA) data.
- Employed Least Absolute Shrinkage and Selection Operator (LASSO) Cox regression to build a prognostic signature.
- Generated a nomogram for predicting individual patient survival outcomes.
Main Results
- Identified 19 cuproptosis-related genes and 14 prognostic cuproptosis-related lncRNAs.
- Developed a seven-lncRNA prognostic risk signature with good predictive accuracy (1-, 3-, 5-year AUCs: 0.711, 0.673, 0.684).
- High-risk group showed worse prognosis, linked to tumorigenesis, migration, high chemokines, T-cell inhibition, and low antigen-presenting cells.
Conclusions
- Cuproptosis-related lncRNAs play a significant role in bladder cancer tumorigenesis.
- These lncRNAs represent potential therapeutic targets for bladder cancer.
- An individualized predictive signature based on cuproptosis-related lncRNAs was successfully constructed.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
02:39
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
03:18
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...

